{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T17:12:31Z","timestamp":1725297151817},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00120-006-1022-x","type":"journal-article","created":{"date-parts":[[2006,3,13]],"date-time":"2006-03-13T16:38:08Z","timestamp":1142267888000},"page":"429-435","source":"Crossref","is-referenced-by-count":3,"title":["Therapie der akuten unkomplizierten Harnweginfektion","Therapy of the acute uncomplicated urinary tract infection"],"prefix":"10.1007","volume":"45","author":[{"given":"F. M. E.","family":"Wagenlehner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Hoyme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. G.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1022_CR1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/00365540410019642","volume":"36","author":"Ferry","year":"2004","unstructured":"Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ (2004) The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 36(4): 296\u2013301","journal-title":"Scand J Infect Dis"},{"key":"1022_CR2","first-page":"729","volume":"52","author":"Christiaens","year":"2002","unstructured":"Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM (2002) Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 52(482): 729\u2013734","journal-title":"Br J Gen Pract"},{"key":"1022_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0924-8579(03)00229-2","volume":"22","author":"Kahlmeter","year":"2003","unstructured":"Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 22 [Suppl 2]: 49\u201352","journal-title":"Int J Antimicrob Agents"},{"key":"1022_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/dkg028","volume":"51","author":"Kahlmeter","year":"2003","unstructured":"Kahlmeter G (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51(1): 69\u201376","journal-title":"J Antimicrob Chemother"},{"key":"1022_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00042307-199901000-00010","volume":"9","author":"Naber","year":"1999","unstructured":"Naber KG (1999) Short-term therapy of acute uncomplicated cystitis. Curr Opin Urol 9(1): 57\u201364","journal-title":"Curr Opin Urol"},{"key":"1022_CR6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","volume":"29","author":"Warren","year":"1999","unstructured":"Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE (1999) Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29(4): 745\u2013758","journal-title":"Clin Infect Dis"},{"key":"1022_CR7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2004.02106.x","volume":"58","author":"Goettsch","year":"2004","unstructured":"Goettsch WG, Janknegt R, Herings RM (2004) Increased treatment failure after 3-days\u2018 courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol 58(2): 184\u2013189","journal-title":"Br J Clin Pharmacol"},{"key":"1022_CR8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/339812","volume":"34","author":"Raz","year":"2002","unstructured":"Raz R, Chazan B, Kennes Y et al. (2002) Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 34(9): 1165\u20131169","journal-title":"Clin Infect Dis"},{"key":"1022_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(98)00021-1","volume":"10","author":"Minassian","year":"1998","unstructured":"Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD (1998) A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 10(1): 39\u201347","journal-title":"Int J Antimicrob Agents"},{"key":"1022_CR10","first-page":"2387","volume":"94","author":"Henning","year":"1997","unstructured":"Henning C, Bengtsson L (1997) Treatment of acute urinary disorders. Simple tests and questions make the diagnosis and therapeutic choices easier. Lakartidningen 94(25): 2387\u20132390","journal-title":"Lakartidningen"},{"key":"1022_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jac\/26.suppl_B.147","volume":"26","author":"Petersen","year":"1990","unstructured":"Petersen EE, Wingen F, Fairchild KL et al. (1990) Single dose pefloxacin compared with multiple dose co-trimoxazole in cystitis. J Antimicrob Chemother 26 [Suppl B]: 147\u2013152","journal-title":"J Antimicrob Chemother"},{"key":"1022_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/AAC.39.1.215","volume":"39","author":"Jardin","year":"1995","unstructured":"Jardin A, Cesana M (1995) Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection-Rufloxacin Group. Antimicrob Agents Chemother 39(1): 215\u2013220","journal-title":"Antimicrob Agents Chemother"},{"key":"1022_CR13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/AAC.40.2.408","volume":"40","author":"Del Rio","year":"1996","unstructured":"Del Rio G, Dalet F, Aguilar L, Caffaratti J, Dal-Re R (1996) Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations. Antimicrob Agents Chemother 40(2): 408\u2013412","journal-title":"Antimicrob Agents Chemother"},{"key":"1022_CR14","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0149-2918(02)80099-6","volume":"24","author":"Henry","year":"2002","unstructured":"Henry DC Jr, Bettis RB, Riffer E et al. (2002) Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther 24(12): 2088\u20132104","journal-title":"Clin Ther"},{"key":"1022_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365540110080728","volume":"34","author":"Nicolle","year":"2002","unstructured":"Nicolle LE, Madsen KS, Debeeck GO et al. (2002) Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 34(7): 487\u2013492","journal-title":"Scand J Infect Dis"},{"key":"1022_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/46.suppl_1.35","volume":"46","author":"Nicolle","year":"2000","unstructured":"Nicolle LE (2000) Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother 46 [Suppl 1]: 35\u201365","journal-title":"J Antimicrob Chemother"},{"key":"1022_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkg280","volume":"52","author":"Kahlmeter","year":"2003","unstructured":"Kahlmeter G, Menday P (2003) Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 52(1): 128\u2013131","journal-title":"J Antimicrob Chemother"},{"key":"1022_CR18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/AAC.47.3.897-900.2003","volume":"47","author":"Kavatha","year":"2003","unstructured":"Kavatha D, Giamarellou H, Alexiou Z et al. (2003) Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women. Antimicrob Agents Chemother 47(3): 897\u2013900","journal-title":"Antimicrob Agents Chemother"},{"key":"1022_CR19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.293.8.949","volume":"293","author":"Hooton","year":"2005","unstructured":"Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE (2005) Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 293(8): 949\u2013955","journal-title":"JAMA"},{"key":"1022_CR20","doi-asserted-by":"crossref","unstructured":"Lecomte F, Allaert FA (1996) Le traitement monodose de la cystite par fosfomycin trometamol. Analyse de 15 essais comparatifs portant sur 2048 malades. M\u00e9d Malad Infect 26: 338\u2013343","DOI":"10.1016\/S0399-077X(96)80209-5"},{"key":"1022_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0924-8579(03)00231-0","volume":"22","author":"Schito","year":"2003","unstructured":"Schito GC (2003) Why fosfomycin trometamol as first line therapy for uncomplicated UTI? Int J Antimicrob Agents 22 [Suppl 2]: 79\u201383","journal-title":"Int J Antimicrob Agents"},{"key":"1022_CR22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003495-200161030-00004","volume":"61","author":"Guay","year":"2001","unstructured":"Guay DR (2001) An update on the role of nitrofurans in the management of urinary tract infections. Drugs 61(3): 353\u2013364","journal-title":"Drugs"},{"key":"1022_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70309-6","volume":"85","author":"Cunha","year":"2001","unstructured":"Cunha BA (2001) Antibiotic side effects. Med Clin North Am 85(1): 149\u2013185","journal-title":"Med Clin North Am"},{"key":"1022_CR24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/42.3.363","volume":"42","author":"Brumfitt","year":"1998","unstructured":"Brumfitt W, Hamilton-Miller JM (1998) Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years\u2018 experience. J Antimicrob Chemother 42(3): 363\u2013371","journal-title":"J Antimicrob Chemother"},{"key":"1022_CR25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.ju.0000130653.74548.d6","volume":"172","author":"Karpman","year":"2004","unstructured":"Karpman E, Kurzrock EA (2004) Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. J Urol 172(2): 448\u2013453","journal-title":"J Urol"},{"key":"1022_CR26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archinte.1995.00430050061007","volume":"155","author":"Iravani","year":"1995","unstructured":"Iravani A, Tice AD, McCarty J et al. (1995) Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group. Arch Intern Med 155(5): 485\u2013494","journal-title":"Arch Intern Med"},{"key":"1022_CR27","first-page":"469","volume":"170","author":"Vogel","year":"2004","unstructured":"Vogel T, Verreault R, Gourdeau M, Morin M, Grenier-Gosselin L, Rochette L (2004) Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ 170(4): 469\u2013473","journal-title":"CMAJ"},{"key":"1022_CR28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/AAC.33.6.877","volume":"33","author":"Backhouse","year":"1989","unstructured":"Backhouse CI, Matthews JA (1989) Single-dose enoxacin compared with 3-day treatment for urinary tract infection. Antimicrob Agents Chemother 33(6): 877\u2013880","journal-title":"Antimicrob Agents Chemother"},{"key":"1022_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9343(20)31145-1","volume":"94","author":"Iravani","year":"1993","unstructured":"Iravani A (1993) Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med 94(3A): 89\u201396","journal-title":"Am J Med"},{"key":"1022_CR30","unstructured":"Iravani A CP, Maladorno D (1995) Fleroxacin in the treatment of uncomplicated urinary tract infections in women. 7th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1995 March 26\u201330, Vienna, Austria"},{"key":"1022_CR31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0090-4295(01)01562-X","volume":"59","author":"Richard","year":"2002","unstructured":"Richard GA, Mathew CP, Kirstein JM, Orchard D, Yang JY (2002) Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 59(3): 334\u2013339","journal-title":"Urology"},{"key":"1022_CR32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijantimicag.2003.12.017","volume":"23","author":"Naber","year":"2004","unstructured":"Naber KG, Allin DM, Clarysse L et al. (2004) Gatifloxacin 400\u00a0mg as a single shot or 200\u00a0mg once daily for 3 days is as effective as ciprofloxacin 250\u00a0mg twice daily for the treatment of patients with uncomplicated urinary tract infections. Int J Antimicrob Agents 23(6): 596\u2013605","journal-title":"Int J Antimicrob Agents"},{"key":"1022_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-4295(98)00160-5","volume":"52","author":"Richard","year":"1998","unstructured":"Richard GA, Klimberg IN, Fowler CL, Callery-D\u2019Amico S, Kim SS (1998) Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Urology 52(1): 51\u201355","journal-title":"Urology"},{"key":"1022_CR34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/00365549209062463","volume":"24","author":"Neringer","year":"1992","unstructured":"Neringer R, Forsgren A, Hansson C, Ode B (1992) Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group. Scand J Infect Dis 24(6): 773\u2013780","journal-title":"Scand J Infect Dis"},{"key":"1022_CR35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/AAC.37.3.574","volume":"37","author":"Nicolle","year":"1993","unstructured":"Nicolle LE, DuBois J, Martel AY, Harding GK, Shafran SD, Conly JM (1993) Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. Antimicrob Agents Chemother 37(3): 574\u2013579","journal-title":"Antimicrob Agents Chemother"},{"key":"1022_CR36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/33.suppl_A.121","volume":"33","author":"Spencer","year":"1994","unstructured":"Spencer RC, Moseley DJ, Greensmith MJ (1994) Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. J Antimicrob Chemother 33 [Suppl A]: 121\u2013129","journal-title":"J Antimicrob Chemother"},{"key":"1022_CR37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/00365548809035662","volume":"20","author":"The","year":"1988","unstructured":"The Inter-Nordic Urinary Tract Infection Study Group (1988) Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. Scand J Infect Dis 20(6): 619\u2013624","journal-title":"Scand J Infect Dis"},{"key":"1022_CR38","first-page":"644","volume":"47","author":"Piipo","year":"1990","unstructured":"Piipo TPT, Salo SA (1990) Three-day versus seven-day treatment with norfloxacin in acute cystitis. Curr Ther Res 47: 644\u2013653","journal-title":"Curr Ther Res"},{"key":"1022_CR39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2165\/00003495-198700341-00022","volume":"34","author":"Block","year":"1987","unstructured":"Block JM, Walstad RA, Bjertnaes A et al. (1987) Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. Drugs 34 [Suppl 1]: 100\u2013106","journal-title":"Drugs"},{"key":"1022_CR40","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1128\/AAC.33.8.1308","volume":"33","author":"Hooton","year":"1989","unstructured":"Hooton TM, Latham RH, Wong ES, Johnson C, Roberts PL, Stamm WE (1989) Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob Agents Chemother 33(8): 1308\u20131312","journal-title":"Antimicrob Agents Chemother"},{"key":"1022_CR41","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1128\/AAC.35.7.1479","volume":"35","author":"Hooton","year":"1991","unstructured":"Hooton TM, Johnson C, Winter C et al. (1991) Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother 35(7): 1479\u20131483","journal-title":"Antimicrob Agents Chemother"},{"key":"1022_CR42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0924-8579(94)90009-4","volume":"4","author":"Naber","year":"1994","unstructured":"Naber KG BW, Fischer M, Kresken M (1994) Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials. Int J Antimicrob Agents 4: 197\u2013202","journal-title":"Int J Antimicrob Agents"},{"key":"1022_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0924-8579(02)00171-1","volume":"20","author":"Menday","year":"2002","unstructured":"Menday AP (2002) Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection. Int J Antimicrob Agents 20(4): 297\u2013300","journal-title":"Int J Antimicrob Agents"},{"key":"1022_CR44","first-page":"34","volume":"37","author":"Gossius","year":"1985","unstructured":"Gossius GVL (1985) The treatment of acute dysuria-frequency syndrome in adult women: double-blind, randomized comparison of three-day vs. ten-day trimethoprim therapy. Curr Ther Res 37: 34\u201342","journal-title":"Curr Ther Res"},{"key":"1022_CR45","unstructured":"Kunin C (1997) Detection, prevention and management of UTIs, 5th edn. Lea\u00a0&\u00a0Febiger, Philadelphia"},{"key":"1022_CR46","first-page":"56","volume":"69","author":"Kass","year":"1956","unstructured":"Kass E (1956) Asymptomatic infections of the urinary tract. Trans Assoc Am Phys 69: 56\u201364","journal-title":"Trans Assoc Am Phys"},{"key":"1022_CR47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000052486","volume":"39","author":"Hamm","year":"2001","unstructured":"Hamm M, Wawroschek F, Weckermann D et al. (2001) Unenhanced helical computed tomography in the evaluation of acute flank pain. Eur Urol 39(4): 460\u2013465","journal-title":"Eur Urol"},{"key":"1022_CR48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7326\/0003-4819-106-3-341","volume":"106","author":"Stamm","year":"1987","unstructured":"Stamm WE, McKevitt M, Counts GW (1987) Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial. Ann Intern Med 106(3): 341\u2013345","journal-title":"Ann Intern Med"},{"key":"1022_CR49","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","volume":"283","author":"Talan","year":"2000","unstructured":"Talan DA, Stamm WE, Hooton TM et al. (2000) Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 283(12): 1583\u20131590","journal-title":"JAMA"},{"key":"1022_CR50","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.ju.0000106191.11936.64","volume":"171","author":"Talan","year":"2004","unstructured":"Talan DA, Klimberg IW, Nicolle LE, Song J, Kowalsky SF, Church DA (2004) Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 171(1): 734\u2013739","journal-title":"J Urol"},{"key":"1022_CR51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijantimicag.2003.09.002","volume":"23","author":"Naber","year":"2004","unstructured":"Naber KG, Bartnicki A, Bischoff W et al. (2004) Gatifloxacin 200\u00a0mg or 400\u00a0mg once daily is as effective as ciprofloxacin 500\u00a0mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections. Int J Antimicrob Agents 23 [Suppl 1]: 41\u201353","journal-title":"Int J Antimicrob Agents"},{"key":"1022_CR52","first-page":"29","volume":"10","author":"Naber","year":"2001","unstructured":"Naber KG, Hauke W (2001) Cefpodoxime proxetil in patients with acute uncomplicated pyelonephritis. International, prospective, randomized comparative study versus ciprofloxacin in general practice. Chemother J 10: 29\u201334","journal-title":"Chemother J"},{"key":"1022_CR53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0195-6701(98)90274-2","volume":"38","author":"Finkelstein","year":"1998","unstructured":"Finkelstein R, Kassis E, Reinhertz G, Gorenstein S, Herman P (1998) Community-acquired urinary tract infection in adults: a hospital viewpoint. J Hosp Infect 38(3): 193\u2013202","journal-title":"J Hosp Infect"},{"key":"1022_CR54","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1742-1241.1999.tb11816.x","volume":"53","author":"Nicolle","year":"1999","unstructured":"Nicolle LE (1999) Pivmecillinam for the treatment of acute uncomplicated urinary infection. Int J Clin Pract 53(8): 612\u2013617","journal-title":"Int J Clin Pract"},{"key":"1022_CR55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01716044","volume":"22","author":"Bailey","year":"1994","unstructured":"Bailey RR (1994) Single-dose\/short-term therapy in children and in pregnant women. Infection 22 [Suppl 1]: 47\u201348","journal-title":"Infection"},{"key":"1022_CR56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0924-8579(00)00351-4","volume":"17","author":"Krcmery","year":"2001","unstructured":"Krcmery S, Hromec J, Demesova D (2001) Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents 17(4): 279\u2013282","journal-title":"Int J Antimicrob Agents"},{"key":"1022_CR57","first-page":"409","volume":"57","author":"Gilstrap","year":"1981","unstructured":"Gilstrap LC 3rd, Cunningham FG, Whalley PJ (1981) Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol 57(4): 409\u2013413","journal-title":"Obstet Gynecol"},{"key":"1022_CR58","unstructured":"Anonymus (2005) Antimicrobials in pregnancy. FDA pregnancy categories. Anonymus"},{"key":"1022_CR59","unstructured":"K\u00e4mmerer WME (2002) Pharmaka und Schwangerschaft \u2013 Eine \u00dcbersicht. In: Freise KMF (ed) Arzneimitteltherapie in der Frauenheilkunde. Wissenschaftliche Verlagsgesellschaft, Stuttgart"},{"key":"1022_CR60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/archinte.1960.00270140016003","volume":"105","author":"Kass","year":"1960","unstructured":"Kass EH (1960) Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 105: 194\u2013198","journal-title":"Arch Intern Med"},{"key":"1022_CR61","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/infdis\/169.6.1390","volume":"169","author":"Gratacos","year":"1994","unstructured":"Gratacos E, Torres PJ, Vila J, Alonso PL, Cararach V (1994) Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis. J Inf Dis 169: 1390\u20131392","journal-title":"J Inf Dis"},{"key":"1022_CR62","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","volume":"40","author":"Nicolle","year":"2005","unstructured":"Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America, American Society of Nephrology, American Geriatric Society (2005) Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40: 643\u2013654","journal-title":"Clin Infect Dis"},{"key":"1022_CR63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01716044","volume":"22","author":"Bailey","year":"1994","unstructured":"Bailey RR (1994) Single-dose\/short-term therapy in children and in pregnant women. Infection 22 [Suppl 1]: 47\u201348","journal-title":"Infection"},{"key":"1022_CR64","doi-asserted-by":"crossref","unstructured":"Villar J, Lydon-Rochelle MT, Gulmezoglu AM, Roganti A (2000) Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev CD000491","DOI":"10.1002\/14651858.CD000491"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-006-1022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-006-1022-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-006-1022-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T18:46:47Z","timestamp":1683398807000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-006-1022-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1007\/s00120-006-1022-x","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}